21 May 2013
Keywords: dey, chiesi, curosurf, oked, fda, food, drug
Article | 25 November 1999
The US Food and Drug Administration has approved Dey LP and ChiesiFarmaceutici SpA Italy's Curosurf (poractant alfa intratracheal suspension), a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.